INTRASTROMAL VORICONAZOLE AS A PRIMARY TREATMENT FOR CLINICALLY DIAGNOSED FUNGAL KERATITIS IN CHILDREN.
M., E., E., N., H., S., A., S. (2023). INTRASTROMAL VORICONAZOLE AS A PRIMARY TREATMENT FOR CLINICALLY DIAGNOSED FUNGAL KERATITIS IN CHILDREN.. EKB Journal Management System, 6(1), 9-15. doi: 10.21608/ejco.2023.305200
Elkadim, M.; Nassar, E.; Saad, H.; Sharaf, A.. "INTRASTROMAL VORICONAZOLE AS A PRIMARY TREATMENT FOR CLINICALLY DIAGNOSED FUNGAL KERATITIS IN CHILDREN.". EKB Journal Management System, 6, 1, 2023, 9-15. doi: 10.21608/ejco.2023.305200
M., E., E., N., H., S., A., S. (2023). 'INTRASTROMAL VORICONAZOLE AS A PRIMARY TREATMENT FOR CLINICALLY DIAGNOSED FUNGAL KERATITIS IN CHILDREN.', EKB Journal Management System, 6(1), pp. 9-15. doi: 10.21608/ejco.2023.305200
M., E., E., N., H., S., A., S. INTRASTROMAL VORICONAZOLE AS A PRIMARY TREATMENT FOR CLINICALLY DIAGNOSED FUNGAL KERATITIS IN CHILDREN.. EKB Journal Management System, 2023; 6(1): 9-15. doi: 10.21608/ejco.2023.305200